Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement ...

EpiVax, Inc. announces a new study published in Frontiers in Immunology unveiling the impact of peptides known as "Tregitopes ...

"We are pleased to contribute this finding to the literature on immune regulation and antibody design." EpiVax is a leader in preclinical immunogenicity assessment and sequence optimization for ...

EpiVax, Inc. announces a new study published in Frontiers in Immunology unveiling the impact of peptides known as "Tregitopes" on antibody maturation ...

De Groot. "We are pleased to contribute this finding to the literature on immune regulation and antibody design." EpiVax is a leader in preclinical immunogenicity assessment and sequence optimization ...

De Groot. "We are pleased to contribute this finding to the literature on immune regulation and antibody design." About EpiVax EpiVax is a leader in preclinical immunogenicity assessment and sequence ...

De Groot. “We are pleased to contribute this finding to the literature on immune regulation and antibody design.” EpiVax is a leader in preclinical immunogenicity assessment and sequence optimization ...

Starting from validated partner sequences, B-Body Express™ manages expression, purification, and quality control - delivering ready-to-use B-Body bispecific antibodies to accelerate early ...